{
    "statements": [
        {
            "id": "moa.assertion:188",
            "description": "BRAF V600E mutations were associated with sensitivity to the BRAF inhibitor PLX-4032 in a study of 109 microdissected pancreatic ductal adenocarcinoma patients.",
            "evidence_level": "moa.evidence_level:Clinical_evidence",
            "proposition": "proposition:623",
            "variation_origin": "somatic",
            "variation_descriptor": "moa.variant:149",
            "therapy_descriptor": "moa.normalize.therapy:Vemurafenib",
            "disease_descriptor": "moa.normalize.disease:oncotree%3APAAD",
            "method": "method:4",
            "supported_by": [
                "pmid:25855536"
            ],
            "type": "Statement"
        }
    ],
    "propositions": [
        {
            "id": "proposition:623",
            "type": "therapeutic_response_proposition",
            "predicate": "predicts_sensitivity_to",
            "subject": "ga4gh:VA.8JkgnqIgYqufNl-OV_hpRG_aWF9UFQCE",
            "object_qualifier": "ncit:C8294",
            "object": "rxcui:1147220"
        }
    ],
    "variation_descriptors": [
        {
            "id": "moa.variant:149",
            "type": "VariationDescriptor",
            "label": "BRAF p.V600E (Missense)",
            "extensions": [
                {
                    "type": "Extension",
                    "name": "moa_representative_coordinate",
                    "value": {
                        "chromosome": "7",
                        "start_position": "140453136.0",
                        "end_position": "140453136.0",
                        "reference_allele": "A",
                        "alternate_allele": "T",
                        "cdna_change": "c.1799T>A",
                        "protein_change": "p.V600E",
                        "exon": "15.0"
                    }
                },
                {
                    "type": "Extension",
                    "name": "moa_rsid",
                    "value": "rs113488022"
                }
            ],
            "variation_id": "ga4gh:VA.8JkgnqIgYqufNl-OV_hpRG_aWF9UFQCE",
            "variation": {
                "_id": "ga4gh:VA.8JkgnqIgYqufNl-OV_hpRG_aWF9UFQCE",
                "type": "Allele",
                "location": {
                    "_id": "ga4gh:VSL.AqrQ-EkAvTrXOFn70_8i3dXF5shBBZ5i",
                    "type": "SequenceLocation",
                    "sequence_id": "ga4gh:SQ.WaAJ_cXXn9YpMNfhcq9lnzIvaB9ALawo",
                    "interval": {
                        "type": "SequenceInterval",
                        "start": {
                            "type": "Number",
                            "value": 639
                        },
                        "end": {
                            "type": "Number",
                            "value": 640
                        }
                    }
                },
                "state": {
                    "type": "LiteralSequenceExpression",
                    "sequence": "E"
                }
            },
            "gene_context": "moa.normalize.gene:BRAF",
            "vrs_ref_allele_seq": "V"
        }
    ],
    "gene_descriptors": [
        {
            "id": "moa.normalize.gene:BRAF",
            "type": "GeneDescriptor",
            "label": "BRAF",
            "gene_id": "hgnc:1097"
        }
    ],
    "therapy_descriptors": [
        {
            "id": "moa.normalize.therapy:Vemurafenib",
            "type": "TherapyDescriptor",
            "label": "Vemurafenib",
            "therapy_id": "rxcui:1147220"
        }
    ],
    "disease_descriptors": [
        {
            "id": "moa.normalize.disease:oncotree%3APAAD",
            "type": "DiseaseDescriptor",
            "label": "Pancreatic Adenocarcinoma",
            "disease_id": "ncit:C8294"
        }
    ],
    "methods": [
        {
            "id": "method:4",
            "label": "Clinical interpretation of integrative molecular profiles to guide precision cancer medicine",
            "url": "https://www.biorxiv.org/content/10.1101/2020.09.22.308833v1",
            "version": {
                "year": 2020,
                "month": 9,
                "day": 22
            },
            "authors": "Reardon, B., Moore, N.D., Moore, N. et al.",
            "type": "Method"
        }
    ],
    "documents": [
        {
            "id": "pmid:25855536",
            "label": "Witkiewicz AK, Mcmillan EA, Balaji U, et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015;6:6744.",
            "xrefs": [
                "doi:10.1038/ncomms7744"
            ],
            "type": "Document"
        }
    ]
}